Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
复制标题
用于治疗楔形切除术后非小细胞肺癌的 GammaClip™ 169Yb 低剂量率永久植入近距离放射治疗源的剂量测定特征。
DOI:
10.1118/1.4812675
复制
发表时间:
2013
期刊:
影响因子:
3.8
通讯作者:
Medich,DavidC
中科院分区:
文献类型:
--
作者:
Currier,Blake;Munro3rd,JohnJ;Medich,DavidC
Purpose:A novel169Yb low dose rate permanent implant brachytherapy source, the GammaClip™, was developed by Source Production & Equipment Co. (New Orleans, LA) which is designed similar to a surgical staple while delivering therapeutic radiation. In this report, the brachytherapy source was characterized in terms of “Dose calculation for photon‐emitting brachytherapy sources with average energy higher than 50 keV: Report of the AAPM and ESTRO” by Perez‐Calatayudet al.[Med. Phys. 39, – (2012)] 10.1118/1.3703892 using the updated AAPM Task Group Report No. 43 formalism.Methods:Monte Carlo calculations were performed using Monte Carlo N‐Particle 5, version 1.6 in water and air, the in‐air photon spectrum filtered to remove photon energies below 10 keV in accordance with TG‐43U1 recommendations and previously reviewed169Yb energy cutoff levels [D. C. Medich, M. A. Tries, and J. M. Munro, “Monte Carlo characterization of an Ytterbium‐169 high dose rate brachytherapy source with analysis of statistical uncertainty,” Med. Phys. 33, 163–172 (2006)] 10.1118/1.2147767. TG‐43U1 dosimetric data, includingSK, , Λ,gL(r),F(r,θ),ϕan(r), and were calculated along with their statistical uncertainties. Since the source is not axially symmetric, an additional set of calculations were performed to assess the resulting axial anisotropy.Results:The brachytherapy source's dose rate constant was calculated to be (1.22 ± 0.03) cGy h−1U−1. The uncertainty in the dose to water calculations, , was determined to be 2.5%, dominated by the uncertainties in the cross sections. The anisotropy constant, , was calculated to be 0.960 ± 0.011 and was obtained by integrating the anisotropy factor between 1 and 10 cm using a weighting factor proportional tor−2. The radial dose function was calculated at distances between 0.5 and 12 cm, with a maximum value of 1.20 at 5.15 ± 0.03 cm. Radial dose values were fit to a fifth order polynomial and dual exponential regression. Since the source is not axially symmetric, angular Monte Carlo calculations were performed at 1 cm which determined that the maximum azimuthal anisotropy was less than 8%.Conclusions:With a higher photon energy, shorter half‐life and higher initial dose rate169Yb is an interesting alternative to125I for the treatment of nonsmall cell lung cancer.
登录
查看更多内容
DOI:
--
发表时间:
2003
期刊:
Medical Physics (Lancaster)
影响因子:
--
作者:
T. Bohm;P. Deluca;L. Dewerd
通讯作者:
L. Dewerd
影响因子:
1.9
作者:
Leonard,KaraLynne;DiPetrillo,ThomasA;Munro,JohnJ;Wazer,DavidE
通讯作者:
Wazer,DavidE
影响因子:
3.8
作者:
Cazeca, Mario J.;Medich, David C.;Munro, John J., III
通讯作者:
Munro, John J., III
DOI:
--
发表时间:
2001
期刊:
Medical Physics (Lancaster)
影响因子:
--
作者:
M. Rivard
通讯作者:
M. Rivard
影响因子:
3.8
作者:
Perez-Calatayud, Jose;Ballester, Facundo;Williamson, Jeffrey F.
通讯作者:
Williamson, Jeffrey F.